Aytu BioPharma logo

Aytu BioPharma

AYTU | NASDAQ
Chart Builder DCF Calculator
$1.82
+$0.04 (+2.25%)
At close: Nov 16, 2026, 4:00 PM ET
$2.62
+$0.80 (+43.97%)
After-hours: Nov 16, 2026, 7:59 PM ET
+2.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
41.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #474/1021 (Top 46%)

Key Statistics

Market Data

Market Cap $22.42M
1D Range
1.75 1.87
52W Range
1.75 2.90

Valuation (TTM)

PE -1.10
PB 0.64
EV/EBITDA -1.68

Valuation (NTM)

Forward PE 117.50
Forward PEG 0.03
Price Target $15.00
Loading financial charts...

Profile

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international m...

Sector Healthcare
Employees 76
IPO Date Sep 25, 2008
Website aytubio.com
Fiscal Year July - June

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.2
Beat +22.08%
REV
$14.84M
Beat +11.84%
Next Earnings
Feb 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$15.00
Upside
+724.18%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.